| http://www.w3.org/ns/prov#value | - The invention further contemplates that pharmaceutical compositions comprising one or more other active agents may be administered separately from the IL-1?? binding antibodies or fragments, and such separate administrations may be performed at the same point or different points in time, such as for example the same or different days.
|
